Infection Control Today analysis
As people with HIV live longer due to ART, new challenges are emerging. Aging with HIV is linked to higher risks of comorbidities, chronic inflammation, and drug interactions, while gaps in clinical trial inclusion and care models highlight the need for more integrated, patient-centered treatment strategies.
While the focus of HIV therapeutic development remains on advancing ART-based medicines, developers are increasingly called to design therapies and care models that account for multimorbidity and the unique physiological needs of older adults with HIV. An article in Infection Control Today examines the shifting clinical profile of aging with HIV, the research gaps affecting this population, and the implications for drug development.
Read the full analysis here.
Source : Infection Control Today
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.